For the Inventor, By the Inventor

Enter assignee name

Jerusalem, Israel

Clexio Biosciences Ltd.

USPTO Granted Patents = 34

CIPO Patents = 2

EPO Patents = 5

Trademarks = 4

Forward Citations = 64

Loading Chart...

Loading Chart...

25 inventors (with patents filed for the assignee):

Ilan Zalit (9 out of 9 patents)

Avshalom Ben Menachem (9 out of 9 patents)

Elena Kagan (8 out of 8 patents)

4. Derek V Moe (8 out of 19 patents)

5. Gina Pastino (6 out of 6 patents)

6. Dinesh K Haswani (6 out of 10 patents)

7. Manuel A Vega Zepeda (6 out of 14 patents)

8. Victoria Ann O'Neill (6 out of 19 patents)

9. Randal A Seburg (5 out of 7 patents)

10. Richard Fisher (4 out of 4 patents)

11. David Dangoor (4 out of 4 patents)

12. Yael Rosen (3 out of 3 patents)

13. Sagar Rane (2 out of 2 patents)

14. Johanna Schumann (2 out of 2 patents)

15. Dorit Mimrod (2 out of 2 patents)

34 patents: Sort by Forward Citations

1. 12478592 - Dosage regime with esketamine for treating neuropsychiatric or neurological conditions (2025-11-25),

2. 12364672 - Esketamine for use in treating major depressive disorder (2025-07-22),

3. 12336970 - Method of treating major depressive disorder (2025-06-24),

4. 12280022 - Method of treating major depressive disorder (2025-04-21),

5. 12268658 - Dosage regime with esketamine for treating major depressive disorder (2025-04-08),

6. 12239634 - Methods of treating pruritus (2025-03-04),

7. 12076300 - Dosage regime with esketamine for treating major depressive disorder (2024-09-03),

8. 12036189 - Method of treating major depressive disorder (2024-07-16),

9. 12016832 - Method of treating major depressive disorder (2024-06-25),

10. 11992468 - Abuse-deterrent dosage forms containing esketamine (2024-05-28),

11. 11964120 - Long acting gastric residence system (2024-04-23),

12. 11957645 - Method of treating major depressive disorder (2024-04-16),

13. 11903928 - Methods of treating pruritus (2024-02-20),

14. 11865088 - Method of treating major depressive disorder (2024-01-09),

15. 11844796 - Immediate release abuse-deterrent granulated dosage forms (2023-12-19),

Clexio Biosciences Ltd. is a leading biotechnology company specializing in the development of innovative therapies for various diseases. With a focus on precision medicine, Clexio integrates cutting-edge technologies to deliver personalized treatment options. Our dedicated team of scientists and researchers are committed to advancing the field of biosciences and improving patient outcomes. Visit our website for more information about our breakthrough therapies and latest research.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

34 Patents

#6 in Jerusalem

#145 in Israel

#19,058 in the World

Jerusalem, Israel

Clexio Biosciences Ltd.

Forward Citations = 64

25 inventors:

Ilan Zalit (9 out of 9 patents)

Avshalom Ben Menachem (9 out of 9 patents)

Elena Kagan (8 out of 8 patents)

4. Derek V Moe (8 out of 19 patents)

5. Gina Pastino (6 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…